Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies
Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies
Recruiting · NCT06028074 · Registry updated 2026-08-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies | Advanced Solid Malignancies | Recruiting | Phase 1 / Phase 2 | 2026-08-17 | NCT06028074 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Georgiamune Inc | 2 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Florida Cancer Specialists | Sarasota | United States | 47 |
| NEXT Oncology Dallas | Irving | United States | 9 |
| Norton Cancer Institute | Louisville | United States | 26 |
| Rutgers Cancer Institute of Nj | New Brunswick | United States | 3 |
| Tennessee Oncology, PLLC | Nashville | United States | 30 |
| Texas Oncology - Baylor Sammons Cancer Center | Dallas | United States | 1 |
| The Angeles Clinic and Research Institute | Los Angeles | United States | 16 |
| UCLA Hematology/Oncology | Los Angeles | United States | 12 |
| UCSF Helen Diller Family Comprehensive Cancer Center | San Francisco | United States | 11 |
| USC/Norris Comprehensive Cancer Center | Los Angeles | United States | 35 |
| Virginia Commonwealth University | Richmond | United States | 156 |